To reduce a woman's risk of endometrial

There are several different types of drugs that can be used to treat osteoporosis. This class of drugs which include alendronate (eg, Fosamax), Ibandronat (eg, Boniva) and ryzedronat (E. g, Actonel), is used to prevent and treat osteoporosis in women and men. Bisphosphonates work by slowing down the speed of thinning bones, which may prevent of osteoporosis and reduces the risk of fractures in people who already have osteoporosis. They take inside. Alendronate Alendronate use (eg, Fosamax) leads to displacement of bone balance toward bone formation by inhibiting bone resorption and has been shown to increase bone mass Alendronate much more than estrogen, but its ability to prevent fractures is very similar to estrogen Lieberman, etc. -. 10. mg alendronate daily for three-year period based bone mass in 96% of patients and reduces the risk of fracture significantly fracture intervention Court Brown, etc. -. with the use of alendronate was 47% reduction in new vertebral fractures by 50% decrease in hip fractures, 55% lower risk of symptomatic vertebral fractures by 48% less than in the wrist, and 28% lower risk of all clinical fractures. Ibandronat Approved for postmenopausal osteoporosis, Ibandronat (eg, Boniva) taken orally once a month. Use Ibandronat reduces bone loss, increases bone density and reduces the risk of fractures of the spine. ryzedronat approved for postmenopausal osteoporosis and osteoporosis glucocorticoids (eg, from prolonged use of prednisone or cortisone ) ryzedronat (eg, Actonel) taken orally for daily or weekly. ryzedronat use reduces bone loss, increases bone density and reduces the risk of spinal fractures and no spine. Calcitonin (eg, Miacalcin, Calcimar, Fortical) is a hormone that naturally produced in the body, and is now available as a medicine. It can be taken by injection or intranasal (through the nose spray). It was found to increase bone density mainly in the spine. calcitonin designed for patients at approximately 5 years after menopause with low bone mass, or with explicit osteoporosis who prefer not to or can not take estrogen. calcitonin also been shown to be useful for relieving pain compression fractures. effectiveness of calcitonin tends to plateau after about 18 years after menopause. In the study of anti-resorptive agents for two years, was compared with placebo, estrogen, calcitonin and alendronate increase bone density were noted with all agents, namely:.

There was no residual protection against bone loss after stopping estrogen and calcitonin However, after stopping alendronate surplus bones were reported. raloksifen, selective estrogen receptor modulator (SERM)

name Evista, raloksifen is part of the Selective Estrogen lasix dosing Receptor Modulators (SERMs) class of drugs designed to ensure the benefits of estrogen without their drawbacks . approved for postmenopausal osteoporosis, raloksifen taken internally every day and leads to increased bone mass and reduces the risk of fractures of the spine.

estrogen replacement therapy was widely used to treat menopausal symptoms in postmenopausal women. To reduce a woman's risk of endometrial cancer, doctors often prescribe the hormone progestin in combination with estrogen for those women with an intact uterus. This combination is called ET / HT (estrogen therapy / hormone replacement therapy). Because of its ability to reduce the risk of fractures of the hip and spine in postmenopausal women, estrogen replacement therapy and ET / HT is also used in the treatment of osteoporosis. However, recent research suggests that some type of hormone replacement is associated with the growth of breast cancer, stroke and heart attack. As a result, now the FDA advises patients to consider other osteoporosis drugs first and use ET / HT conservative (eg, low dose, short term) to cope with the symptoms of menopause. Teriparatide (eg, brand name Forteo) is the only approved treatment for osteoporosis >> << that increases bone formation (rather than slow down bone loss), resulting to increase bone mineral density. This man-made form of natural parathyroid hormone, which regulates the metabolism of calcium and phosphate in bones. Teriparatide is intended for use within 24 months as a daily self-injection in men with high risk of fractures in postmenopausal women. In men, studies show reduction of fractures in the spine, in postmenopausal women, fracture reduction was demonstrated in the spine, hips and other bones of the National Osteoporosis Foundation .. Access on May 19, 2006 National Institute of Health - Program Development Consent: Optimal consumption calcium .. Access .. on June 14, 2006.

,